Physician profile
Perry Halvatzis
NPI 1528099694
$1,956.46
in general payments reported to CMS, 2019-2025
16 companies · $201 in 2025
The $201 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $179 · 2021: $327 · 2022: $382 · 2023: $241 · 2024: $134 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $576.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $407.40 | 2021-2025 | Tearcare System |
| Sun Pharmaceutical Industries INC. | $323.91 | 2020-2023 | Cequa |
| Alcon Vision LLC | $177.02 | 2019-2023 | Precision 1 |
| Bausch & Lomb Americas INC. | $157.06 | 2022-2025 | Infuse, Miebo |
| Johnson & Johnson Vision Care, INC. | $138.42 | 2019-2022 | |
| Hoffmann-La Roche Limited | $125.00 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $119.88 | 2019-2020 | |
| Biotissue Holdings INC. | $112.38 | 2019 | |
| Amgen INC. | $111.17 | 2024 | Uplizna |
| Lkc Technologies, INC. | $93.94 | 2022 | |
| Shire North American Group INC | $58.37 | 2019 | |
| Coopervision INC. | $50.02 | 2024-2025 | Clariti Contact Lens |
| Maculogix, INC. | $27.08 | 2020 | |
| Oyster Point Pharma, INC. | $22.59 | 2025 | Tyrvaya, Ryzumvi |
| Harrow Eye, LLC | $18.09 | 2025 | Vevye |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $14.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perry Halvatzis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.